Fåhraeus Startup and Growth is a venture capital fund that invests in early stage Life Science and tech companies with cutting-edge innovative solutions.

Arcede Pharma (publ) develops new patent-protected drug candidates with focus on chronic obstructive pulmonary disease (COPD) and severe asthma with the aim to improve quality of life, reduce suffering and prolong life expectancy.

SAGA Diagnostics is a personalised cancer medicine and disease monitoring company focused on molecular genetic analyses of circulating tumor DNA and cancer biopsies.In these roles, I was responsible for building strategic relationships with our customers to grow SAGA’s business and for the effective execution of SAGAs operations, which consists of both service laboratory (ISO 17025) and kit manufacturing of RUO and CE-marked products.

I had the overall responsibility for the innovation activity within the life science area at Lund University, leading a team of five people. Coordinating the value chain from academia to start-up.Operating board member in startups.Supported our projects/companies to raise significant external fundingEstablished and maintained strong strategic relationships between university, industry and investors.

I am a Business Developer at LU Innovation System focusing on cancer projects. My role is to work together with scientists in order to identify and evaluate commercially viable projects and to facilitate the commercial process from an idea to a company start-up or outlicensing.

SAGA Diagnostics is a personalized cancer medicine and disease monitoring company. Precision Cancer Medicine is now. We provide molecular genetic tests and services for healthcare, biopharmaceutical companies, and academia. Based on leading research from Lund University, Sweden, our proprietary and patent-pending molecular genetic tests are part of a revolution in cancer companion diagnostics and monitoring. Our tests quantify circulating tumor DNA (ctDNA) — a powerful new biomarker — to detect cancer, measure response to therapy, and decipher the cancer-specific DNA mutations that may be targetable with clinically-approved drugs or therapies currently in clinical trials.

SmiLe Incubator help entrepreneurs and early-stage companies develop and commercialize new ideas in life science, bringing together bright minds to share powerful ideas.

SARomics Biostructures provides a broad range of structural biology services that include FastLane™ Standard and FastLane™ Premium off-the-shelf structures, gene-to-structure and protein NMR spectroscopy services. Our recently introduced structural services also include testing, analysis and validation of the higher order structure (HOS) of biosimilars. The company's integrated drug discovery platform relies on our unique and proprietary weak affinity chromatography screening technology (WAC™). We provide fragment screening and fragment-based drug design as well as computational chemistry and in silico drug discovery services. Our highly experienced and competent team of crystallographers, modellers and molecular biologists, allow us to offer to our customers quick and efficient services at highly competitive prices.

* Focus on vaccines and diagnostics, primarily within TB. *Secure commercialization of SSI’s IPR and know-how* Identify and evaluate commercial potential in projects and products (e.g. making commercialization strategies, market and business plans) * Prepare, review and negotiate license, consortium, material transfer and confidentiality agreements* Ensure alliance management with SSI’s licensees and licensors. * Coordinate teams of researchers, patent attorneys and legal advisors to advance our commercial and academic partnerships .

As a project leader of two of Intercell’s preclinical vaccine projects, it was my responsibility to coordinate and prioritize the project activities performed both in-house at the different departments and with external collaborators. In addition, I supervised a master student at the Department of Adjuvant Research. Also, I performed different in vitro and in vivo studies.